A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide
2013
Medical Council
Preserved Fulltext
Diabetes mellitus type 2 is a chronic progressive disease which leads to specific vascular complications - microangiopathy and macroangiopathy. These complications are the reason of increased cardiovascular mortality, which is 4-5 times higher in patients with type 2 diabetes mellitus than in the general population.
doi:10.21518/2079-701x-2013-9-70-75
doaj:bbdc1f1db45f41b99a7687213c164a62
fatcat:cyuc6rxsojdg7fys25cdb5imbi